Pigmentation disorders
Tranexamic Acid for Melasma: Evaluating the Various Formulations
by Jordan V. Wang, MD, MBE, MBA; Nikita Jhawar, BS; and Nazanin Saedi, MD Drs. Wang and Saedi are with the Department of Dermatology and Cutaneous Biology at Thomas Jefferson University in Philadelphia, Pennsylvania. Ms. Jhawar is with the Drexel University College of Medicine in Philadelphia, Pennsylvania. FUNDING: No funding was provided for this study. […]
Evaluating the Efficacy, Safety, and Tolerability of the Combination of Tazarotene, Azelaic Acid, Tacrolimus, and Zinc Oxide for the Treatment of Melasma: A Pilot Study
J Clin Aesthet Dermatol. 2019;12(5)40–45 by Brandon Kirsch, MD; Paul M. Hoesly, MD; Anokhi Jambusaria, MD, MSCE; Michael G. Heckman, MS; Nancy N. Diehl, MS; and Jason C. Sluzevich, MD Drs. Kirsch (at the time of this study), Hoesly (at the time of this study), and Sluzevich are with the Department of Dermatology at the […]
Willingness-to-pay and Time Trade-off: The Burden of Disease in Patients with Benign Hyperpigmentation
J Clin Aesthet Dermatol. 2019;12(5):46–48 by Mayra B. C. Maymone, MD, DSc; Susruthi Rajanala, BA; Rafael Widjajahakim, MS; Eric Secemsky, MD, MSc; Dana Saade, MD; and Neelam A. Vashi, MD Drs. Maymone, Saade, and Vashi, Ms. Rajanala, and Mr. Widjajahakim are with the Department of Dermatology at the Boston University School of Medicine in Boston, Massachusetts. […]
Vitamin C Prevents Ultraviolet-induced Pigmentation in Healthy Volunteers: Bayesian Meta-analysis Results from 31 Randomized Controlled versus Vehicle Clinical Studies
J Clin Aesthet Dermatol. 2019;12(2):E53–E59 (epub only) by Romain de Dormael, PharmD;* Philippe Bastien, PhD;* Peggy Sextius, PhD; Audrey Gueniche, PharmD; Daniel Ye, PhD; Christian Tran, PharmD; Véronique Chevalier, MSc; Charles Gomes, PhD; Luc Souverain, MSc; and Caroline Tricaud, PhD Drs. de Dormael, Bastien, Sextius, Gueniche, Tran, Gomes, and Mr. Souverain are with L’Oréal Research […]
Acquired Macular Pigmentation of Unknown Etiology
J Clin Aesthet Dermatol. 2019;12(1):38–46 by Siriorn Udompanich, MBchB, MSc and Vasanop Vachiramon, MD Dr. Udompanich and Dr. Vachiramon are with the Division of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University in Bangkok, Thailand. Funding: No funding was provided for this study. Disclosures: The authors have no conflicts of interest relevant to the content […]
Patterns of Over-the-counter Lightening Agent Use among Patients with Hyperpigmentation Disorders: A United States-based Cohort Study
by Dana S. Saade, MD; Mayra B.C. Maymone, MD, DSc; Eric A. Secemsky, MD, MSc; Kevin F. Kennedy, MSc; and Neelam A. Vashi, MD Drs. Saade, Maymone, and Vashi are with the Department of Dermatology at Boston University School of Medicine in Boston, Massachusetts. Dr. Secemsky is with the Department of Medicine at Massachusetts General […]
Dual Effect of Photobiomodulation on Melasma: Downregulation of Hyperpigmentation and Enhanced Solar Resistance—A Pilot Study
by Daniel Barolet, MD, FRCPC Dr. Barolet is with the Department of Medicine, Dermatology Division, McGill University in Montreal, Québec, Canada, and with the RoseLab Skin Optics Laboratory in Laval, Canada. Funding: No funding was provided for this article. Disclosures: The author has no conflicts of interest relevant to the content of this article. Abstract: […]
